Skip to main content

Tegaserod Pregnancy and Breastfeeding Warnings

Brand names: Zelnorm

Tegaserod Pregnancy Warnings

Tegaserod has been assigned to pregnancy category B by the FDA. Animal studies have revealed no evidence of fetal harm. There are no controlled data in human pregnancy. Tegaserod is only recommended for use during pregnancy when the benefit outweighs the risk.

See references

Tegaserod Breastfeeding Warnings

There are no data on the excretion of tegaserod into human milk. In studies with lactating rats, tegaserod and its metabolites were excreted in milk with a high milk to plasma ratio. Due to the potential for tumorigenicity reported in animal studies, the manufacturer recommends that a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

See also

References for pregnancy information

  1. Product Information. Zelnorm (tegaserod). Novartis Pharmaceuticals. 2002.

References for breastfeeding information

  1. Product Information. Zelnorm (tegaserod). Novartis Pharmaceuticals. 2002.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer